... of one of the trials. He is senior director and head of translational genetics at the Regeneron Genetics Center in Tarrytown, N.Y. Evinacumab -- an antibody-based therapy developed by Dewey and his team -- reduced levels of triglycerides up to 76 ...
http://ift.tt/2r5rpWA
No comments:
Post a Comment